Measles virus isolated from the brain of a patient with subacute sclerosing panencephalitis was injected intracerebrally (ic) into 34 rhesus monkeys. Groups of these animals were injected with measles antigen in Freund's complete adjuvant or treated by schedules used for suppression of the general or cell-mediated immune responsiveness. In another group of animals, experimental allergic encephalitis was induced parallel with measles infection. Measles virus was isolated from the brains of monkeys up to 13 days after ic inoculation. No virus was detected in the central nervous system after 3 to 4 weeks, the longest postinoculation period examined. It was concluded that the subacute sclerosing panencephalitis-derived virus either lost its neurotropic properties at the passage level at which it was used or that it submerged into a silent stage and escaped detection. Neither immunosuppression nor concomitant autoimmune encephalitis had an effect on the survival of measles virus in the central nervous system. The histology of the nervous tissue was basically normal except for characteristic lesions of experimental allergic encephalitis in animals receiving the respective treatment.
Encephalitides in the postinfectious period of several common exanthematous diseases of childhood or after vaccination against rabies and smallpox are thought to depend largely on immune reactions directed against brain antigens, viral antigens, or both, in the brain tissue proper (12, 21) . The frequent failure to isolate an infectious agent from the central nervous system (CNS) in fatal cases of encephalitis has supported the above view (21) .
With improved virus isolation techniques, several isolations of measles virus were made from brains of patients with subacute sclerosing panencephalitis (SSPE) and these viruses were shown to possess altered physical and cultural properties (5, 6, (9) (10) (11) 18) . When one of the strains was injected intracerebrally into monkeys, the animals developed serum antibody but failed to show neurological symptoms over a 3-month observation period (10) . The measles virus reference vaccine (DBS lot 2) and Difco Freund's complete adjuvant (FCA). The potency of the antigen was tested in rats (Lewis strain) and in guinea pigs (Hartley strain). Animals injected with 0.1 ml of the sensitizing antigen and skin-tested 14 days later developed indurations measuring 6 to 15 mm in diameter (see below).
Other animals were inoculated intradermally into five sites on the shaved back with a total of 0.5 ml of a CNS antigen consisting of a mixture of equal volumes of 40% guinea pig spinal cord homogenate and FCA.
Immunosuppression. 
RESULTS
General experimental design. The general design of the study is illustrated in Fig. 1 . The animals in group 2 were injected ic with measles virus, and the clinical course of disease, laboratory data, and histopathology were compared with the results obtained in group 1 animals inoculated with tissue culture fluid only. Groups 3 and 4 consisted of specifically suppressed animals or those in which suppression was induced by Cytoxan, respectively. The effect of hypersensitivity against measles antigen, encephalitogenic antigen, or both, on measles infection was studied in the last four groups. The ic injection of measles virus in all groups was scheduled so that maximal ic virus multiplication would coincide with maximal expected hypersensitivity or immunosuppression.
From recent observations of newly arrived monkeys and based on previous studies, it was expected that on arrival at the laboratory the animals would be in an early stage of measles incubation. It was anticipated that starting treatment immediately on arrival would produce the above immunological effects. To prevent possible interference ofviral replication after ic inoculation of Ro-SSPE-1 virus strain by circulating natural wild-type virus, monkeys in groups 2, 4, 7, and 8 received an initial intravenous dose of 1 ml of a high-titered measles hyperimmune monkey serum.
Clinical course of disease. Rash was observed in 12 of 32 animals between day 2 and 6 of the experiment (Table 1) . It was most pronounced on the face and resulted in a small degree of scaling a few days later. In the untreated, uninfected group 1, two animals died on days 1 and 6 after ic inoculation, respectively (Fig. 1) . Virus isolation attempted only from the second animal was unsuccessful (Table 2 ). In the untreated, measles-infected group 2, two animals died 2 days after ic inoculation, probably as a result of trauma. Measles virus was isolated from the brain of both animals.
One of the remaining two animals developed a slight hemiparesis several days before sacrifice.
In the specifically suppressed group 3, one animal died 3 days after inoculation and one animal developed weakness of the left arm 4 days before sacrifice. In the Cytoxan-treated group 4, one animal died 1 day after inoculation. Two animals died 13 In the measles-sensitized, infected group 5, one animal developed transient weakness and jerkiness of the left arm 6 days after ic inoculation. Of the total of 12 animals sensitized with guinea pig cord (groups 6, 7, and 8), 3 died, 4 and 8 days after ic infection, respectively, and measles virus was isolated from the brains of all three. Of the remaining nine animals, seven developed pronounced symptoms of EAE (e.g., visual disturbances, impaired pupillary reflexes, nystagmus, generalized weakness, tremor, cerebellar ataxia) which persisted until their sacrifice. The four ani-mals in group 6, which were sensitized with measles antigen in addition to receiving brain tissue, developed symptoms of EAE comparable to those of animals sensitized with brain antigen only.
Results of virological and immunological investigations. In Table 1 , the results of serological studies and the skin tests for delayed hypersensitivity are shown. The untreated, uninfected animals in group 1 developed measles antibodies during the third week of the experiment. Seroconversion was considered the result of the spontaneous infection which the animals apparently acquired shortly before they were used in the experiment. A similar antibody response developed in the untreated, ic measles-inoculated animals in group 2 and in animals (group 3) receiving the treatment for specific suppression of delayed hypersensitivity. An almost complete suppression of the humoral antibody response was achieved in the Cytoxan-treated animals (group 4). Seroconversion in the young adult animals (groups 5 to 8) generally started earlier, indicating that the spontaneous infection in these animals was probably more advanced than in the adolescent animals (groups 1 to 4).
Sensitization of groups 5 and 6 with measles antigen in FCA did not produce the desired effect. Although the antibody response appeared accelerated, the 24-hr skin test failed to show evidence of a significant reaction for delayed hypersensitivity (Table 1) .
Eleven animals became sick and died during the course of the experiment. Histological study of the brain tissue and virus isolation attempts were performed in eight of these animals. Virus was isolated from the CNS of all seven animals inoculated ic with measles virus ( (1, 8) .
Lesions of EAE in monkeys were observed in groups 6, 7, and 8 (Table 1) . Typically, these lesions consisted of extensive, diffuse perivascular infiltrates throughout the brain stem and cerebrum (14, 22) . Two of the animals in group 8 had more acute coalescent, demyelinating lesions. Significantly, no inclusion bodies were found in any of the infiltrates. The lesions in all three groups were similar and apparently were not modified by measles infection or sensitization.
DISCUSSION
There is accumulating evidence that acute and chronic measles encephalitis in man is the consequence of a direct invasion and multiplication of measles virus in the CNS (1, 10, 18) . In acute encephalitis, hypersensitivity to measles antigen coupled with an autoimmune reaction to damaged brain tissue was thought to be an essential component of the disease (12, 17) . In contrast, the chronic form of measles encephalitis (SSPE) was thought to develop as a consequence of an acquired defect of cell-mediated immunity in the presence of a normal antibody response (7) .
Circumstances which determine the persistence and pathogenicity of measles virus in the nervous tissue can be only indirectly implied from observations in laboratory animals and in cell cultures.
To investigate the effect of altered immunological responsiveness on Apparently, generalized measles infection in the present experiment was too advanced for the sensitizing antigen to be effective.
The advanced stage of infection might also explain the failure of passive immunization to prevent rash in animals so treated. In fact, it was found that immune serum given to patients in an advanced stage of measles infection precipitated a typical skin rash (13) .
VOL. 4, 1971 SCHUMAC Strain Ro-SSPE-1 was isolated from the brain of ic-infected monkeys up to 13 days after inoculation ( Table 2 ). The unsuccessful attempts to isolate the virus at later intervals may reflect a failure of the virus to become adapted to grow in nervous tissue and, thus, to escape elimination by the developing antibody response. A similar mechanism for suppression of the potential neurotropism of distemper virus in experimentally infected puppies was postulated by Appel (2) . None of the altered immunological situations induced in monkeys had a perceptible effect on the result of ic inoculation of the Ro-SSPE-1 strain.
The absence of specific morphological lesions in the CNS of the monkeys and the failure to isolate the virus 3 to 4 weeks after ic inoculation indicates that at this stage the virus was either eliminated or entered into a latent state. However, one cannot exclude the possibility that a small focus of persisting viral activity may have escaped morphological or virological detection.
